Patents by Inventor A. Sue Menko

A. Sue Menko has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DRUG-INDUCED EPIGENETIC REMODELING TO PREVENT FIBROSIS
    Publication number: 20220401454
    Abstract: A therapeutic treatment for preventing or reducing the formation of fibrosis comprising administering to a patient a UTX or JMJD3 inhibitor that are effective in preventing or reducing fibrosis in situations wherein access to an injury or dysmorphogenetic tissues before the fibrotic process becomes established in the tissues.
    Type: Application
    Filed: July 7, 2022
    Publication date: December 22, 2022
    Applicant: Thomas Jefferson University
    Inventors: Janice L. Walker, Alexander Mazo, Svetlana Petruk, A. Sue Menko
  • Drug-induced epigenetic remodeling to prevent fibrosis
    Patent number: 11400099
    Abstract: A therapeutic treatment for preventing or reducing the formation of fibrosis comprising administering to a patient a UTX or JMJD3 inhibitor that are effective in preventing or reducing fibrosis in situations wherein access to an injury or dysmorphogenetic tissues before the fibrotic process becomes established in the tissues.
    Type: Grant
    Filed: September 25, 2017
    Date of Patent: August 2, 2022
    Assignee: THOMAS JEFFERSON UNIVERSITY
    Inventors: Janice L. Walker, Alexander Mazo, Svetlana Petruk, A. Sue Menko
  • DRUG-INDUCED EPIGENETIC REMODELING TO PREVENT FIBROSIS
    Publication number: 20200016166
    Abstract: A therapeutic treatment for preventing or reducing the formation of fibrosis comprising administering to a patient a UTX or JMJD3 inhibitor that are effective in preventing or reducing fibrosis in situations wherein access to an injury or dysmorphogenetic tissues before the fibrotic process becomes established in the tissues.
    Type: Application
    Filed: September 25, 2017
    Publication date: January 16, 2020
    Applicant: Thomas Jefferson University
    Inventors: Janice L. WALKER, Alexander MAZO, Svetlana PETRUK, Sue A. MENKO
  • Compositions and methods for the treatment and prevention of lens fibrotic diseases
    Patent number: 9273133
    Abstract: Compositions and methods for treating fibrotic diseases are provided.
    Type: Grant
    Filed: December 4, 2009
    Date of Patent: March 1, 2016
    Assignees: Lankenau Institute for Medical Research, Thomas Jefferson University
    Inventors: Allyn Sue Menko, Mindy George-Weinstein, Janice L. Walker, Jacquelyn Gerhart
  • Method to treat and prevent posterior capsule opacification
    Patent number: 8999370
    Abstract: The invention provides a method to treat or prevent posterior capsular opacification. The method comprises administering a therapeutically or prophylactically effective amount of a pharmaceutical composition comprising at least one kinase inhibitor. The kinase inhibitor inhibits p38 kinases, ERK kinases, and/or Src family kinases. The invention also provides an ocular device coated with at least one kinase inhibitor.
    Type: Grant
    Filed: May 26, 2006
    Date of Patent: April 7, 2015
    Assignee: Thomas Jefferson University
    Inventor: Allyn Sue Menko
  • Compositions and Methods for the Treatment and Prevention of Lens Fibrotic Diseases
    Publication number: 20110256054
    Abstract: Compositions and methods for treating fibrotic diseases are provided.
    Type: Application
    Filed: December 4, 2009
    Publication date: October 20, 2011
    Inventors: Allyn Sue Menko, Mindy George-Weinstein, Janice L, Walker, Jacquelyn Gerhart
  • Method to Treat and Prevent Posterior Capsule Opacification
    Publication number: 20080193504
    Abstract: The invention provides a method to treat or prevent posterior capsular opacification. The method comprises administering a therapeutically or prophylactically effective amount of a pharmaceutical composition comprising at least one kinase inhibitor. The kinase inhibitor inhibits p38 kinases, ERK kinases, and/or Src family kinases. The invention also provides an ocular device coated with at least one kinase inhibitor.
    Type: Application
    Filed: May 26, 2006
    Publication date: August 14, 2008
    Inventor: Allyn Sue Menko